Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/131010
COMPARTIR / EXPORTAR:
SHARE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Klippstein, Rebecca | - |
dc.contributor.author | Pozo, David | - |
dc.date.accessioned | 2016-04-12T11:49:03Z | - |
dc.date.available | 2016-04-12T11:49:03Z | - |
dc.date.issued | 2011 | - |
dc.identifier | issn: 1877-9123 | - |
dc.identifier | e-issn: 1877-9131 | - |
dc.identifier.citation | Recent Patents on Nanomedicine 1(1): 55-59 (2011) | - |
dc.identifier.uri | http://hdl.handle.net/10261/131010 | - |
dc.description.abstract | Nanotechnology can address key bottlenecks hindering successful bench to bedside translation of recent research in the development of neuropeptide-based drugs. This is the case for vasoactive intestinal peptide (VIP), where sustained interest in its therapeutic applications needs to devise new methodologies to improve its drugability or to convey innovation to diagnostics to identify cells that result from conditions such as carcinoid metastasis in which VPAC receptors are involved. We analyze here current technologies and patent disclosing methods on surface functionalization or encapsulation to obtain VIP engineered nanoparticles. | - |
dc.description.sponsorship | We gratefully acknowledge the financial support provided by the Spanish Ministry of Health (PS09-2252); the Andalusian Ministry of Health (PI-2008-0068), the Andalusian Ministry of Economy, Science and Innovation (Proyecto Excelencia CTS-6928) and the PAIDI Program from the Andalusian Government (CTS-677). | - |
dc.publisher | Bentham Science Publishers | - |
dc.rights | closedAccess | - |
dc.subject | Cancer | - |
dc.subject | VIP | - |
dc.subject | VIP receptors | - |
dc.subject | Surface funcionalization | - |
dc.subject | Immunomodulation | - |
dc.subject | Neuropeptide | - |
dc.title | Engineered nanoparticles for improved vasoactive intestinal peptide (VIP) biomedical applications | - |
dc.type | artículo | - |
dc.date.updated | 2016-04-12T11:49:03Z | - |
dc.description.version | Peer Reviewed | - |
dc.language.rfc3066 | eng | - |
dc.contributor.funder | Junta de Andalucía | - |
dc.contributor.funder | Ministerio de Sanidad, Servicios Sociales e Igualdad (España) | - |
dc.relation.csic | Sí | - |
dc.identifier.funder | http://dx.doi.org/10.13039/501100003751 | es_ES |
dc.identifier.funder | http://dx.doi.org/10.13039/501100011011 | es_ES |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | es_ES |
item.openairetype | artículo | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
Aparece en las colecciones: | (CABIMER) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
Page view(s)
170
checked on 29-mar-2024
Download(s)
78
checked on 29-mar-2024
Google ScholarTM
Check
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.